Company / Assets per Share
BioRestorative Therapies, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.59
FY2025
5-year range
$0.59 / $31.38
FY2021-FY2025
Trend
-77.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 4 consecutive years, from $31.38 in FY2021 to $0.59 in FY2025.
Based on SEC 10-K filings.
0.59 in FY2025 with a 5-year CAGR of +60.2%.
Declined from $3.43 to $0.59 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -49.8%
- 5-Year CAGR
- +60.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- BioRestorative Therapies, Inc.'s assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 77.4% year-over-year.
- Peak assets per share was recorded in FY2021.
- Lowest assets per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.59 | -77.4% |
| FY2024 | $2.61 | -23.9% |
| FY2023 | $3.43 | -26.5% |
| FY2022 | $4.67 | -85.1% |
| FY2021 | $31.38 | +56097.9% |
| FY2020 | $0.06 | -55.3% |
| FY2019 | $0.13 | -35.9% |
| FY2018 | $0.20 | -47.9% |
| FY2017 | $0.37 | -21.6% |
| FY2016 | $0.48 | -59.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026